Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Case-Control Study
69%
Non-Steroidal Anti-Inflammatory Drug
42%
Statin (Protein)
35%
Anticoagulant Agent
35%
Malignant Neoplasm
33%
Antivitamin K
30%
Prevalence
28%
Drug Utilization
27%
Cerebrovascular Accident
26%
Atrial Fibrillation
23%
Comorbidity
22%
Acetylsalicylic Acid
22%
Upper Gastrointestinal Bleeding
20%
Brain Hemorrhage
20%
Heart Infarction
20%
Selective Serotonin Reuptake Inhibitor
19%
SARS Coronavirus
18%
Brain Ischemia
18%
Infection
17%
Antidepressant
17%
Prescription Drug
16%
Cardiovascular Disease
16%
Adverse Drug Reaction
16%
Warfarin
16%
Polypharmacy
15%
Chronic Obstructive Lung Disease
14%
All Cause Mortality
13%
Proton Pump Inhibitor
13%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
13%
Phthalic Acid
12%
Helicobacter Pylori
12%
Observational Study
12%
Pharmacotherapy
12%
Overactive Bladder
12%
Medication Error
11%
Antibiotics
11%
Antiplatelet
11%
Adverse Outcome
11%
Randomized Clinical Trial
10%
Peptic Ulcer Bleeding
10%
Defined Daily Dose
10%
Randomized Controlled Trial
9%
Cardiovascular Risk
9%
Angiotensin Receptor Antagonist
9%
Pharmacovigilance
9%
Ischemic Heart Disease
9%
Bleeding
9%
Diseases
9%
Prostate Cancer
9%
Medicine and Dentistry
Cohort Analysis
80%
Case-Control Study
40%
Odds Ratio
35%
Antithrombotic
28%
Drug Use
25%
Hazard Ratio
23%
Cardiovascular System
22%
Nonsteroid Antiinflammatory Agent
22%
Malignant Neoplasm
22%
Vitamin K Antagonist
21%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Infection
17%
Atrial Fibrillation
17%
Diabetes
13%
Proton-Pump Inhibitor
12%
Cerebral Hemorrhage
12%
Health Care
11%
Abdominal Aortic Aneurysm
11%
Cardiovascular Disease
11%
Cancer Surgery
10%
Colorectal Carcinoma
10%
Prevalence
10%
Apoplexy
10%
Brain Ischemia
10%
Comorbidity
9%
Antibiotics
9%
Antidepressant
9%
Prescription Drug
8%
Statin
8%
Sepsis
8%
Adverse Outcome
8%
Selective Serotonin Reuptake Inhibitor
8%
Upper Gastrointestinal Bleeding
8%
Cancer Risk
8%
Logistic Regression Analysis
7%
General Practitioner
7%
Emergency Department
7%
Glycon
7%
COVID-19
7%
Medicine
7%
Randomized Controlled Trial
7%
Myocardial Infarction
7%
Drug Therapy
7%
Anticoagulation
6%
Attributable Risk
6%
Coronary Artery Disease
6%
Total Intravenous Anesthesia
6%
Helicobacter Pylori
6%
Skin Cancer
6%
Postoperative Complication
6%
